3rd Circ. Urged Not To Halt Antitrust Suit Over GSK Drug

Law360, New York (February 11, 2013, 7:38 PM EST) -- A pair of drug wholesalers on Friday pressed the Third Circuit not to stay an appeal of their antitrust class action over a generic-drug deal between GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. until the U.S. Supreme Court rules on a related case, arguing the drugmakers haven't shown any hardship absent a stay.

Named plaintiffs Louisiana Wholesale Drug Company Inc. and King Drug Company of Florence Inc. are seeking leave to appeal a New Jersey federal judge's ruling which scuttled their case by holding that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.